stella
beta
Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons — Stella
Recruiting
Back to Meningococcal Meningitis, Serogroup B trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
Belgium
CEVAC, University Hospital Ghent, Belgium, Ghent
View full record on ClinicalTrials.gov